Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Indivior PLC (INDV)

  • Business News
  • Jan. 07, 2026, 18:26 UTC
  • 8
  • 1 comments

Indivior Notification

Market reaction Comment Full text

Indivior PLC (INDV)

  • SEC News
  • Jan. 07, 2026, 18:25 UTC
  • 11
  • 0 comments

New Form 3 - INDIVIOR PLC Filed: 2026-01-07 AccNo: 0002014440-26-000003 Size: 324 KB

Comment Full text

NewAmsterdam Pharma (NAMS)

  • SEC News
  • Jan. 07, 2026, 18:19 UTC
  • 12
  • 1 comments

📋 Michael Davidson (affiliate) plans to sell 12K shares of NewAmsterdam Pharma Co. N.V. (at $35.48 each, total $411K) Filed: Jan 07, 2026 | ID: 000023

Comment Full text

Cosmos Holdings Inc. (COSM)

  • SEC News
  • Jan. 07, 2026, 18:01 UTC
  • 12
  • 1 comments

Siokas Grigorios 🟢 acquired 134.0K shares of Cosmos Health Inc. (COSM) at $0.54 Transaction Date: Jan 06, 2026 | Filing ID: 000059

Comment Full text

TransCode Therapeutics Inc. (RNAZ)

  • SEC News
  • Jan. 07, 2026, 17:39 UTC
  • 12
  • 0 comments

New Form SCHEDULE 13G/A - Transcode Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001535610-26-000003 Size: 9 KB

Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • SEC News
  • Jan. 07, 2026, 17:03 UTC
  • 12
  • 1 comments

📋 Bassler Bonnie L (Director) plans to sell 2K shares of REGENERON PHARMACEUTICALS, INC. (at $800.00 each, total $1.2M) Filed: Jan 07, 2026 | ID: 000001

Comment Full text

GENFIT S.A. (GNFT)

  • Business News
  • Jan. 07, 2026, 17:00 UTC
  • 12
  • 1 comments

GENFIT Announces 2026 Financial Calendar

Market reaction Comment Full text

Cidara Therapeutics Inc. (CDTX)

  • SEC News
  • Jan. 07, 2026, 16:58 UTC
  • 9
  • 0 comments

New Form S-8 POS - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005864 Size: 34 KB

Comment Full text

Cidara Therapeutics Inc. (CDTX)

  • SEC News
  • Jan. 07, 2026, 16:55 UTC
  • 7
  • 0 comments

New Form S-8 POS - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005856 Size: 34 KB

Comment Full text

Cidara Therapeutics Inc. (CDTX)

  • SEC News
  • Jan. 07, 2026, 16:54 UTC
  • 9
  • 0 comments

New Form S-8 POS - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005852 Size: 34 KB

Comment Full text

Cidara Therapeutics Inc. (CDTX)

  • SEC News
  • Jan. 07, 2026, 16:53 UTC
  • 8
  • 0 comments

New Form S-8 POS - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005850 Size: 34 KB

Comment Full text

Cidara Therapeutics Inc. (CDTX)

  • SEC News
  • Jan. 07, 2026, 16:52 UTC
  • 11
  • 0 comments

New Form S-8 POS - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005846 Size: 34 KB

Comment Full text

Cidara Therapeutics Inc. (CDTX)

  • SEC News
  • Jan. 07, 2026, 16:50 UTC
  • 7
  • 0 comments

New Form S-8 POS - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005843 Size: 34 KB

Comment Full text

Cidara Therapeutics Inc. (CDTX)

  • SEC News
  • Jan. 07, 2026, 16:49 UTC
  • 10
  • 0 comments

New Form S-8 POS - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005838 Size: 34 KB

Comment Full text

Cidara Therapeutics Inc. (CDTX)

  • SEC News
  • Jan. 07, 2026, 16:48 UTC
  • 11
  • 0 comments

New Form S-8 POS - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005832 Size: 34 KB

Comment Full text
  • Previous
  • 547
  • 548
  • 549
  • 550
  • 551
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191985)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125295)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin